The Department of Homeland Security (DHS) recently announced intentions to award a sole source contract to Silver Lake Research Corporation (SLRC) for continued development of threat agent specific monoclonal antibodies for which current gold standards methods are not able to generate a highly specific product to support the development of rapid detection assays.
The effort is managed by the DHS Directorate of Science and Technology (S&T), Chemical and Biological Defense Division (CBD).
“SLRC has produced a group of highly specific monoclonal antibodies for use in DHS and FEDGOV assays. The technology and methods used are company proprietary and unavailable from any other source,” states the announcement. “Since the Contractor’s access to their innovative and unique intellectual property are critically necessary to perform the work; the only viable alternative for the Government would be to proceed as recommended with a sole source option and is critical to S&T/CBD that the work be completed.”
S&T CBD requires that SLRC continue and complete the work for the research, development and generation of hyper-specific monoclonal antibodies specific for bacterial and viral biothreat agents.
SLRC is based in Monravia, Calif. The company develops and manufactures innovative very high affinity antibody-based products using a proprietary immunization technology, called the Enhanced Affinity Platform, or EAP™ System.